Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GBIO |
---|---|---|
09:32 ET | 9912 | 3.075 |
09:36 ET | 400 | 2.98 |
09:38 ET | 400 | 2.96 |
09:39 ET | 200 | 2.99 |
09:48 ET | 1200 | 2.98 |
09:52 ET | 100 | 2.93 |
09:54 ET | 200 | 2.92 |
09:56 ET | 200 | 2.91 |
09:57 ET | 1683 | 2.88 |
09:59 ET | 2384 | 2.92 |
10:01 ET | 400 | 2.945 |
10:06 ET | 1071 | 2.93 |
10:08 ET | 133 | 2.96 |
10:12 ET | 100 | 2.93 |
10:14 ET | 100 | 2.93 |
10:15 ET | 600 | 2.93 |
10:17 ET | 200 | 2.93 |
10:19 ET | 500 | 2.9329 |
10:21 ET | 305 | 2.92 |
10:24 ET | 500 | 2.92 |
10:26 ET | 100 | 2.92 |
10:28 ET | 639 | 2.93 |
10:30 ET | 200 | 2.92 |
10:32 ET | 400 | 2.93 |
10:33 ET | 1291 | 2.9399 |
10:39 ET | 600 | 2.93 |
10:42 ET | 100 | 2.92 |
10:44 ET | 200 | 2.91 |
10:46 ET | 1355 | 2.95 |
10:53 ET | 300 | 2.935 |
10:57 ET | 1083 | 2.9407 |
11:02 ET | 300 | 2.94 |
11:04 ET | 500 | 2.925 |
11:06 ET | 100 | 2.9 |
11:08 ET | 1696 | 2.9 |
11:09 ET | 1243 | 2.895 |
11:11 ET | 469 | 2.895 |
11:13 ET | 100 | 2.88 |
11:15 ET | 100 | 2.88 |
11:18 ET | 100 | 2.88 |
11:20 ET | 233 | 2.86 |
11:22 ET | 1547 | 2.875 |
11:24 ET | 662 | 2.89 |
11:29 ET | 700 | 2.89 |
11:31 ET | 200 | 2.89 |
11:33 ET | 835 | 2.89 |
11:36 ET | 200 | 2.88 |
11:38 ET | 100 | 2.8889 |
11:44 ET | 400 | 2.875 |
11:45 ET | 100 | 2.86 |
11:49 ET | 100 | 2.86 |
11:51 ET | 500 | 2.87 |
11:54 ET | 700 | 2.87 |
11:56 ET | 310 | 2.87 |
12:02 ET | 100 | 2.86 |
12:03 ET | 200 | 2.87 |
12:05 ET | 200 | 2.85 |
12:07 ET | 500 | 2.855 |
12:09 ET | 1371 | 2.855 |
12:14 ET | 1300 | 2.85 |
12:16 ET | 500 | 2.84 |
12:20 ET | 500 | 2.82 |
12:21 ET | 1148 | 2.82 |
12:25 ET | 900 | 2.84 |
12:27 ET | 1100 | 2.845 |
12:36 ET | 400 | 2.85 |
12:39 ET | 100 | 2.85 |
12:41 ET | 701 | 2.85 |
12:45 ET | 1248 | 2.84 |
12:48 ET | 100 | 2.845 |
12:50 ET | 1800 | 2.83 |
12:52 ET | 500 | 2.84 |
12:54 ET | 100 | 2.83 |
12:56 ET | 388 | 2.84 |
12:57 ET | 300 | 2.85 |
01:03 ET | 400 | 2.85 |
01:06 ET | 100 | 2.84 |
01:10 ET | 500 | 2.85 |
01:12 ET | 410 | 2.85 |
01:14 ET | 400 | 2.85 |
01:19 ET | 100 | 2.84 |
01:21 ET | 100 | 2.83 |
01:24 ET | 500 | 2.81 |
01:28 ET | 100 | 2.81 |
01:30 ET | 900 | 2.82 |
01:32 ET | 250 | 2.835 |
01:35 ET | 400 | 2.815 |
01:37 ET | 100 | 2.81 |
01:39 ET | 351 | 2.82 |
01:50 ET | 700 | 2.83 |
01:51 ET | 400 | 2.835 |
01:55 ET | 100 | 2.83 |
02:00 ET | 500 | 2.82 |
02:04 ET | 500 | 2.81 |
02:06 ET | 1055 | 2.8 |
02:08 ET | 100 | 2.8 |
02:09 ET | 100 | 2.8 |
02:13 ET | 3867 | 2.8 |
02:18 ET | 300 | 2.8 |
02:20 ET | 2200 | 2.82 |
02:22 ET | 646 | 2.82 |
02:24 ET | 1025 | 2.81 |
02:26 ET | 400 | 2.82 |
02:29 ET | 800 | 2.815 |
02:31 ET | 400 | 2.8 |
02:33 ET | 1612 | 2.79 |
02:38 ET | 1200 | 2.815 |
02:42 ET | 100 | 2.81 |
02:44 ET | 700 | 2.81 |
02:45 ET | 300 | 2.81 |
02:47 ET | 1100 | 2.81 |
02:49 ET | 1400 | 2.83 |
02:51 ET | 400 | 2.83 |
02:54 ET | 200 | 2.82 |
02:56 ET | 500 | 2.81 |
02:58 ET | 100 | 2.81 |
03:00 ET | 100 | 2.81 |
03:02 ET | 600 | 2.81 |
03:03 ET | 100 | 2.81 |
03:05 ET | 593 | 2.8 |
03:07 ET | 400 | 2.8 |
03:09 ET | 650 | 2.82 |
03:12 ET | 200 | 2.8 |
03:14 ET | 500 | 2.8 |
03:16 ET | 100 | 2.8 |
03:18 ET | 600 | 2.8 |
03:21 ET | 1000 | 2.81 |
03:23 ET | 300 | 2.8 |
03:25 ET | 200 | 2.8 |
03:27 ET | 23158 | 2.79 |
03:30 ET | 700 | 2.78 |
03:32 ET | 300 | 2.79 |
03:34 ET | 100 | 2.8 |
03:36 ET | 200 | 2.8 |
03:38 ET | 500 | 2.8 |
03:39 ET | 500 | 2.8 |
03:41 ET | 4564 | 2.8 |
03:43 ET | 300 | 2.78 |
03:45 ET | 700 | 2.78 |
03:48 ET | 4751 | 2.805 |
03:50 ET | 5352 | 2.8 |
03:52 ET | 1000 | 2.79 |
03:54 ET | 2000 | 2.78 |
03:56 ET | 979 | 2.77 |
03:57 ET | 1042 | 2.77 |
03:59 ET | 3273 | 2.78 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Generation Bio Co | 198.1M | -1.4x | --- |
CervoMed Inc | 217.6M | -40.2x | --- |
bluebird bio Inc | 183.4M | -1.3x | --- |
Abeona Therapeutics Inc | 216.9M | -2.9x | --- |
Cardiff Oncology Inc | 201.0M | -4.7x | --- |
X4 Pharmaceuticals Inc | 200.7M | -2.0x | --- |
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $198.1M |
---|---|
Revenue (TTM) | $5.9M |
Shares Outstanding | 66.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.85 |
EPS | $-1.97 |
Book Value | $3.07 |
P/E Ratio | -1.4x |
Price/Sales (TTM) | 33.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,346.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.